SEC Form 4 · accession 0001104659-17-061354
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diane G. Gerst
Officer — EVP, QA & Regulatory Affairs
Period of report
Oct 5, 2017
Accepted (ET)
Oct 6, 2017 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2017 | M | 8,444 | $11.33 | A | 42,792 | D | |
| Common Stock | Oct 5, 2017 | S | 8,444 | $18.8745 | D | 34,348 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $11.33 | Oct 5, 2017 | M | 8,444 | D | — | Mar 17, 2026 | Common Stock | 8,444 | 25,330 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2017.
- F2Shares subject to the option vest in four equal annual installments beginning on March 17, 2017.